In vivo brain microdialysis: advances in neuropsychopharmacology and drug discovery. - Wikidata - awgldk - TriplyDB

In vivo brain microdialysis: advances in neuropsychopharmacology and drug discovery.

In vivo brain microdialysis: advances in neuropsychopharmacology and drug discovery.

http://www.wikidata.org/entity/Q37870701

about

Progressive dopaminergic alterations and mitochondrial abnormalities in LRRK2 G2019S knock-in mice Inducible Nitric Oxide Inhibitors Block NMDA Antagonist-Stimulated Motoric Behaviors and Medial Prefrontal Cortical Glutamate Efflux.Mass spectrometric analysis of carisoprodol and meprobamate in rat brain microdialysates CART peptide is a potential endogenous antioxidant and preferentially localized in mitochondria.Stable isotope dilution HILIC-MS/MS method for accurate quantification of glutamic acid, glutamine, pyroglutamic acid, GABA and theanine in mouse brain tissues.Investigation of signaling molecules and metabolites found in crustacean hemolymph via in vivo microdialysis using a multifaceted mass spectrometric platform.A review of the abuse potential assessment of atomoxetine: a nonstimulant medication for attention-deficit/hyperactivity disorder Emerging trends in in vivo neurochemical monitoring by microdialysis Brain microdialysis and its applications in experimental neurochemistry.Overview of experimental models of the blood-brain barrier in CNS drug discovery.Microfabrication and in Vivo Performance of a Microdialysis Probe with Embedded Membrane.Measuring dopaminergic function in the 6-OHDA-lesioned rat: a comparison of PET and microdialysis.Intraoperative dopamine release during globus pallidus internus stimulation in Parkinson's disease.In Vivo Observation of Structural Changes in Neocortical Catecholaminergic Projections in Response to Drugs of Abuse.Systemic neurotransmitter responses to clinically approved and experimental neuropsychiatric drugs

P2860

Q27308060-F27B7E0D-E9B2-4D5B-A0E8-06F3427D57DA Q27308077-91DB6949-1DD2-47BC-9A58-012183D5967C Q33468993-A2F46A28-6B98-4711-B926-45719A7738CE Q34123653-299CFACB-3440-4CD4-9ED5-9D20FE1C014F Q35649261-61B66F94-97F9-4DDC-996D-3996A4364695 Q35874615-F1A4459A-393F-4646-86F3-AB873AB45D6A Q36630601-0BE687C1-5F6F-4915-9CE8-021EAAF1C857 Q38121653-02940115-786B-48EC-81FD-613016599C9D Q38136077-7F2D94BA-51D6-4AE5-9B9F-B407117A4912 Q38186650-79333CAD-0165-4F2C-A36C-9AC9841D78A6 Q42221590-B9E8E01C-2D53-430E-9F43-ADCAB014B5E9 Q42769988-5C7FF80E-3367-4F5B-91DB-6ABA48D941A6 Q46068097-2F405CD5-A7F0-4C6F-900D-1946E2761E86 Q49347593-3C8AA3A5-9FF3-4ED7-8A0C-7C5A85600696 Q58586423-206D008B-AB8C-459F-ACB9-B0B804545876

P2860

In vivo brain microdialysis: advances in neuropsychopharmacology and drug discovery.

http://www.wikidata.org/entity/Q37870701

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on February 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

In vivo brain microdialysis: advances in neuropsychopharmacology and drug discovery.

@en

In vivo brain microdialysis: advances in neuropsychopharmacology and drug discovery.

@nl

type

label

In vivo brain microdialysis: advances in neuropsychopharmacology and drug discovery.

@en

In vivo brain microdialysis: advances in neuropsychopharmacology and drug discovery.

@nl

prefLabel

In vivo brain microdialysis: advances in neuropsychopharmacology and drug discovery.

@en

In vivo brain microdialysis: advances in neuropsychopharmacology and drug discovery.

@nl

P1433

Q37870701-85531D47-7CFC-49E3-A4BE-BEC4F42FC2C9

P1476

Q37870701-6AD310A8-C6FA-4DA7-A829-AFA102743BFC

P2093

Q37870701-053AEBE1-C8B0-4566-A6D9-A60EFE25E4D7

Q37870701-07A95169-635A-4C48-9D7E-967AA7501B79

Q37870701-23CD720A-9FE5-46F4-8AAA-74B4AA1278CE

Q37870701-279BEDD5-32A0-4E65-859B-33B645BC70CF

Q37870701-63985FF2-464C-4FF2-81E5-B7D061AF79C7

Q37870701-F2E792A8-7C53-426E-AC5B-3B4EA5EEF5C0

P2860

Q37870701-003CF039-D7CF-465B-BC5C-DDB06D98A1A2

Q37870701-011EB375-FA18-487B-9494-4679E207F6A1

Q37870701-06A55E31-7A8F-4358-9FBC-C16F3702FEFB

Q37870701-08E31818-7409-4328-A2A9-CB4885A8C704

Q37870701-0C9D5607-A6C4-4158-89DD-5A120FC75810

Q37870701-0F2FE40F-1701-4182-BA9A-3D09F159AFDD

Q37870701-10E4C93C-DF66-48BA-B84A-767181BBFE23

Q37870701-1314575D-F030-4D3A-9F97-8DBF506900EB

Q37870701-1652AF96-9587-43A7-9ED8-09053D538E9E

Q37870701-1687A6B7-DF3C-4FE5-AEF9-043919248C71

P304

Q37870701-616D223C-3B87-485E-BD40-FF78ACCBE3A0

P31

Q37870701-5CCB1291-D25E-4936-BBBD-9289D39CE71E

P356

Q37870701-589B41D0-064F-422D-AA82-3E75C36DE580

P407

Q37870701-1FB85C64-A41C-43DF-AE9A-AF047C2C7D8C

P433

Q37870701-FEDC61B2-285F-4B70-88FB-192652759365

P478

Q37870701-4245A177-B32D-4C2B-A97D-7308CFC34235

P50

Q37870701-E385D416-5F5B-404C-B76E-93A6D7C8E275

P577

Q37870701-B0A6AF4F-A1F7-4DDF-8170-04C2858FDB9D

P5875

Q37870701-56376FEA-5C66-40E8-8F35-481476584854

P698

Q37870701-1FADD148-9F06-42CC-92AF-578019851247

P932

Q37870701-46FD9045-040A-43BB-84EC-E0C6409CC046

P356

17460441.2011.547189

P1433

Expert Opinion on Drug Discovery

P1476

In vivo brain microdialysis: advances in neuropsychopharmacology and drug discovery.

@en

P2093

Altaf S Darvesh

http://www.w3.org/2001/XMLSchema#string

Charles K Meshul

http://www.w3.org/2001/XMLSchema#string

Cornelis J Van der Schyf

http://www.w3.org/2001/XMLSchema#string

Gary A Gudelsky

http://www.w3.org/2001/XMLSchema#string

Richard T Carroll

http://www.w3.org/2001/XMLSchema#string

Werner J Geldenhuys

http://www.w3.org/2001/XMLSchema#string

P2860

Dual dopamine/serotonin releasers: potential treatment agents for stimulant addiction

Neurochemical neutralization of methamphetamine with high-affinity nonselective inhibitors of biogenic amine transporters: a pharmacological strategy for treating stimulant abuse

Neurochemical and behavioral differences between d-methamphetamine and d-amphetamine in rats

Hippocampus norepinephrine, caudate dopamine and serotonin, and behavioral responses to the stereoisomers of amphetamine and methamphetamine

The serotonin 5-HT6 receptor: a viable drug target for treating cognitive deficits in Alzheimer's disease

Mechanisms of neurotransmitter release by amphetamines: a review

Unraveling monoamine receptors involved in the action of typical and atypical antipsychotics on glutamatergic and serotonergic transmission in prefrontal cortex

Monoamine releasers with varying selectivity for dopamine/norepinephrine versus serotonin release as candidate "agonist" medications for cocaine dependence: studies in assays of cocaine discrimination and cocaine self-administration in rhesus monkeys

Balance between dopamine and serotonin release modulates behavioral effects of amphetamine-type drugs

Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: II. Neurophysiological characterization and broad preclinical efficacy in cognition and schizophrenia of a potent and selective histamine

P304

109-127

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/17460441.2011.547189

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51089122

http://www.w3.org/2001/XMLSchema#string

P698

21532928

http://www.w3.org/2001/XMLSchema#string

P932

3083031

http://www.w3.org/2001/XMLSchema#string